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Abstract
Accumulated evidence, corroborated by a new systematic review by Kristensen et al. (Genome Med 8:52, 2016),
suggests that probiotics do not significantly impact the fecal microbiota composition of healthy subjects. Nevertheless,
physiological benefits have been associated with probiotic consumption by healthy people. Some studies have
suggested that probiotics may impact the function of colonizing microbes, although this needs to be further
studied. An alternative hypothesis is that probiotics may promote homeostasis of the gut microbiota, rather than
change its composition. This hypothesis warrants investigation as a possible mechanism for how probiotics may
benefit healthy people.
Please see related article: http://genomemedicine.biomedcentral.com/articles/10.1186/s13073-016-0300-5.
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Background
The consumption of probiotics has been reported to in-
duce a range of benefits for human health, including
the prevention of necrotizing enterocolitis in premature
infants [1], crying time reduction in colicky babies [2],
reduction in acute pediatric diarrhea duration [3], symptom
management in irritable bowel syndrome [4], and preven-
tion of antibiotic-associated diarrhea [5]. The underlying
mechanism for probiotic functionality is often assumed to
stem from their ability to impact the human microbiota.
However, in a study recently published by Kristensen et al.
[6], the conclusion is that the probiotics tested thus far do
not have a substantive effect on the overall composition of
colonizing gut microbes in healthy adults. Nevertheless,
this finding should not be interpreted to mean that
probiotics have no effect on healthy adults; indeed, nu-
merous controlled intervention trials argue otherwise.
However, Kristensen et al.’s [6] study does suggest that
an alteration in gut microbiota composition is not a
primary mechanism of probiotic functionality.
The extent of the evidence considered in Kristensen et
al.’s [6] review comprises seven randomized controlled
trials that assessed fecal samples from healthy subjects
using shotgun metagenomic sequencing, 16S rRNA
sequencing, or phylogenetic microarray methods. While
most of the included studies covered Lactobacillus
probiotics, the review also included one study each for
Bifidobacterium longum or Bacillus subtilis. Using a
systematic approach, the authors found no effect of
probiotics on fecal microbiota composition when com-
pared to a placebo, as reflected by alpha-diversity, rich-
ness, or evenness. Not included in the Kristensen et al. [6]
study were pre-metagenomic studies, which have demon-
strated that probiotic consumption often increases the
number of related phylotypes and, in some cases, de-
creases opportunistic pathogens and their toxins [7].
Such limited effects are likely masked in comprehensive
metagenomics assessments. These limited compositional
changes notwithstanding, Kristensen et al.’s [6] review
challenges us to reconsider assumptions regarding the
mechanisms behind the documented efficacy of
probiotics.
Probiotic impact on the microbiota
Although outside the scope of the review by Kristensen
et al. [6], another aspect that should be considered is
whether or not probiotics exert an effect on the function
of microbiota as reflected by metatranscriptomic and
metabolomic analyses. Indeed, Eloe-Fadrosh et al. [8]
and McNulty et al. [9] have described such effects. How-
ever, relevance to human health of the metabolic changes
observed thus far remains to be elucidated. The same can
be said for compositional changes. We do not know how
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colonizing populations are established or the causes of
their variability over time. At any given moment, gut
microbiota composition is impacted by so many host
and environmental variables that it is difficult to form
meaningful hypotheses. This point is clearly made
through a recent microbiome analysis of fecal samples
from a total of 3948 healthy subjects, tracking just over
500 metadata variables [10]. Sixty-nine factors were
shown to correlate significantly with overall microbiome
community variation reflected in alpha-diversity and
abundances, yet these variables explained only a small
fraction of the variation of genera present in the com-
munities. Even this large study was not able to deter-
mine the essential factors responsible for determining
the composition of our gut microbiota.
A pressing topic in the probiotic field today is whether
or not probiotics can impact gut microbiota in a manner
that improves the health of the host. Unfortunately, since
the composition of a healthy microbiota remains unknown
[11], there is a lack of robust phylogenetic targets for ex-
ploratory research. Rather than focusing on specific phylo-
genetic changes in composition, a more fruitful approach
could be to assess the ability of probiotics to promote
microbiota stability [12]. Although not a new concept,
surprisingly few studies have addressed the ability of a
probiotic to reinforce the colonizing microbiota’s ability
to either resist perturbation to stressors (for example,
antibiotics, poor diet, psychological stress) or quicken
recovery from said stress. Engelbreckston et al. [13] showed
less antibiotic-induced microbiota disruption in healthy,
probiotic-supplemented adults than in those who did
not take a probiotic. Their study assessed microbiota
changes using both culture techniques and terminal re-
striction fragment length polymorphism. Studies com-
paring metagenomic composition before and after a
stress, with and without a probiotic intervention, could
provide insights into the ability of probiotics to support
host health through stabilizing the microbiota, rather
than fundamentally changing its composition (Fig. 1).
Conclusions
Kristensen et al. [6] have provided incentives to revise
our assumptions of how probiotics might promote
health in humans. Additional research is needed to clar-
ify whether probiotics can instead promote gut micro-
biota homeostasis and thereby minimize the far reaching
effects of microbiota disturbances. Such research may
help resolve this apparent contradiction between the clear
health benefits of probiotics and their lack of impact on
microbiota composition.
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